Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.
Moxalactam was used as initial, empirical therapy in 69 patients with a variety of serious bacterial infections, 32% of which were accompanied by bacteremia. Overall, the success rate was 83% and drug-related adverse effects were minimal. The drug was less efficacious in infections caused by aerobic...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1983
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC184702/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6222696/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.23.4.565 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|